Market revenue in 2023 | USD 47.8 million |
Market revenue in 2030 | USD 76.7 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.31% in 2023. Horizon Databook has segmented the Mexico clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is the second largest market for clinical trials after Brazil and accounts for 20.0% of total clinical trials conducted in Latin America. Rising number of clinical trials in Mexico is boosting the demand for efficient clinical trial supplies, which is attracting market players.
The primary challenge is logistics and supply chain with complicated rules pertaining to import and export permits. COFEPRIS, the ministry of health of Brazil, grants import and export license. For certain classes of drugs and medical supplies, a permit is not required if relevant protocol is followed; however, for majority of the supplies, a permit is required.
Shipments above USD 1,000 require a special permit license, which generally requires an import broker. Complex rules with respect to logistics and supply chain are some of the challenges for clinical trial supply and logistics market players in Mexico.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account